Brief: Lineage Cell Therapeutics Reports Third Quarter Results

Lineage Cell Therapeutics

12/11/2019 21:33

Nov 12 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS REPORTS THIRD QUARTER 2019
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q3 REVENUE $600,000
    * Q3 REVENUE ESTIMATE $808,000 -- REFINITIV IBES DATA
    * QTRLY LOSS PER SHARE $0.11
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED
$35.7
MILLION AS OF SEPTEMBER 30, 2019

Source text for Eikon:  ID:nBw9Z4RJYa 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))